After a drop in coverage led to a sharp upsurge in measles outbreaks last year.

We are self-confident that the knowledge and insights of the outstanding individuals on the Women in Pharmacy Steering Committee, along with responses from all ASHP members, will result in a number of actionable recommendations ASHP can take to greatly help impact and make positive adjustments that will ultimately improve patient treatment and progress pharmacy practice. The Steering Committee will seek input to inform its deliberations and suggestions from all ASHP members over the next 12 months.. Abbvie announces multiple research results of veliparib investigational substance in NSCLC patients AbbVie released interim results from an ongoing Phase 2 research of its investigational compound veliparib in conjunction with chemotherapy, which showed a 35 % improvement in progression-free of charge survival and a thirty % improvement in overall survival in sufferers with previously untreated metastatic or advanced non-little cell lung malignancy .